The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
FOX 9 Minneapolis-St. Paul on MSN4d
Generic prescription drug prices marked up as high as 5,000%, investigation findsA new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...
The industry has come under scrutiny by the Federal Trade Commission. Its first report was released last year. It shows that PBMs profit at the expense of patients and independent pharmacies with ...
We should also consider UnitedHealth Group's role in perpetuating the myth that PBMs help alleviate drug costs for patients. A Federal Trade Commission (FTC) report issued mid-January examined the ...
An earlier FTC report published in July 2024 argued that the six largest PBMs were effectively running a monopoly that gave them enormous power over the price of medicines and allowed them to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback